After asset purchase from Travere, Mirum's Ctexli crosses FDA finish line in rare metabolic disorder
The approval makes chenodiol—already cleared for decades to treat radiolucent gallstones under the brand name Chenodal—the ...
ETH Zurich researchers have investigated how tiny gas bubbles can deliver drugs into cells in a targeted manner using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback